{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:03:00Z","timestamp":1790251380036,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Otorrinolaringol\u00f3gica Espa\u00f1ola"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.otorri.2009.03.008","type":"journal-article","created":{"date-parts":[[2009,9,22]],"date-time":"2009-09-22T08:14:02Z","timestamp":1253607242000},"page":"225-232","source":"Crossref","is-referenced-by-count":24,"title":["V\u00eda intratimp\u00e1nica en el tratamiento de patolog\u00eda de o\u00eddo interno"],"prefix":"10.1016","volume":"61","author":[{"given":"Carlos","family":"Herraiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Miguel Aparicio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Plaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.otorri.2009.03.008_bib1","first-page":"553","article-title":"Myringotomy under topical anesthesia with phenol","volume":"51","author":"Plaza","year":"2000","journal-title":"Acta Otorrinolaringol Esp"},{"key":"10.1016\/j.otorri.2009.03.008_bib2","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1097\/MAO.0b013e31815aee21","article-title":"Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph","volume":"28","author":"Bird","year":"2007","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.otorri.2009.03.008_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005537-199907001-00001","article-title":"Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application","volume":"109","author":"Parnes","year":"1999","journal-title":"Laryngoscope"},{"key":"10.1016\/j.otorri.2009.03.008_bib4","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/MOO.0b013e32830ce796","article-title":"Issues, indications, and controversies regarding intratympanic steroid perfusion","volume":"16","author":"Hamid","year":"2008","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.otorri.2009.03.008_bib5","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.otohns.2007.01.022","article-title":"Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy","volume":"137","author":"Plaza","year":"2007","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.otorri.2009.03.008_bib6","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1097\/01.mao.0000185057.81962.51","article-title":"Oral administration of prednisone to control refractory vertigo in M\u00e9ni\u00e8re's disease: a pilot study","volume":"26","author":"Morales-Luckie","year":"2005","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.otorri.2009.03.008_bib7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.otohns.2005.05.010","article-title":"Dexamethasone inner ear perfusion by intratympanic injection in unilateral M\u00e9ni\u00e8re's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial","volume":"133","author":"Gardu\u00f1o-Anaya","year":"2005","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.otorri.2009.03.008_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/mao.0b013e31815dbafc","article-title":"Longitudinal results with intratympanic dexamethasone in the treatment of M\u00e9ni\u00e8re's disease","volume":"29","author":"Boleas-Aguirre","year":"2008","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.otorri.2009.03.008_bib9","unstructured":"Herraiz [en prensa]"},{"key":"10.1016\/j.otorri.2009.03.008_bib10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.heares.2006.08.010","article-title":"Therapeutic efficacy of intra-cochlear administration of methylprednisolone after acoustic trauma caused by gunshot noise in guinea pigs","volume":"22","author":"Sendowski","year":"2006","journal-title":"Hear Res"},{"key":"10.1016\/j.otorri.2009.03.008_bib11","first-page":"1","article-title":"Intratympanic administration of methylprednisolone reduces impact of experimental intensive impulse noise trauma on hearing","volume":"24","author":"Zhou","year":"2008","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.otorri.2009.03.008_bib12","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1080\/00016480410016621","article-title":"Selective vestibular ablation by intratympanic gentamicin in patients with unilateral active M\u00e9ni\u00e8re's disease: a prospective, double-blind, placebo-controlled, randomized clinical trial","volume":"124","author":"Stokroos","year":"2004","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.otorri.2009.03.008_bib13","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/00129492-200309000-00018","article-title":"Hearing loss after intratympanic gentamicin therapy for unilateral M\u00e9ni\u00e8re's Disease","volume":"24","author":"Martin","year":"2003","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.otorri.2009.03.008_bib14","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00129492-200103000-00016","article-title":"Long-term follow-up of transtympanic gentamicin flor M\u00e9ni\u00e8re's syndrome","volume":"22","author":"Harner","year":"2001","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.otorri.2009.03.008_bib15","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/00129492-200407000-00023","article-title":"Intratympanic gentamicin therapy for M\u00e9ni\u00e8re's disease: a meta-analysis","volume":"25","author":"Chia","year":"2004","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.otorri.2009.03.008_bib16","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1097\/MLG.0b013e31817d01cd","article-title":"Dependence of hearing changes on the dose of intratympanically applied gentamicin: a meta-analysis using mathematical simulations of clinical drug delivery protocols","volume":"118","author":"Salt","year":"2008","journal-title":"Laryngoscope"},{"key":"10.1016\/j.otorri.2009.03.008_bib17","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000089407","article-title":"A new method for drug application to the inner ear","volume":"67","author":"Ito","year":"2005","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"10.1016\/j.otorri.2009.03.008_bib18","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/MAO.0b013e31811f40db","article-title":"Novel therapy for hearing loss: delivery of insulin-like growth factor 1 to the cochlea using gelatin hydrogel","volume":"28","author":"Lee","year":"2007","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.otorri.2009.03.008_bib19","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/01.mlg.0000200791.77819.eb","article-title":"Cochlear protection by local insulin-like growth factor-1 application using biodegradable hydrogel","volume":"116","author":"Iwai","year":"2006","journal-title":"Laryngoscope"},{"key":"10.1016\/j.otorri.2009.03.008_bib20","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.neuropharm.2007.02.007","article-title":"A novel dual inhibitor of calpains and lipid peroxidation (BN82270) rescues the cochlea from sound trauma","volume":"52","author":"Wang","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.otorri.2009.03.008_bib21","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1080\/00016480601110212","article-title":"Intratympanic treatment of acute acoustic trauma with a cell-permeable JNK ligand: a prospective randomized phase I\/II study","volume":"127","author":"Suckfuell","year":"2007","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.otorri.2009.03.008_bib22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00129492-200101000-00005","article-title":"Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation","volume":"22","author":"Chandrasekhar","year":"2001","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.otorri.2009.03.008_bib23","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1067\/mhn.2001.117162","article-title":"Transtympanic steroids for treatment of sudden hearing loss","volume":"125","author":"Gianoli","year":"2001","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.otorri.2009.03.008_bib24","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1097\/00005537-200407000-00010","article-title":"Effectiveness of intratympanic dexamethasone injection in sudden-deafness patients as salvage treatment","volume":"114","author":"Ho","year":"2004","journal-title":"Laryngoscope"},{"key":"10.1016\/j.otorri.2009.03.008_bib25","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/01.mao.0000185052.07513.5a","article-title":"Intratympanic corticosteroids for sudden idiopathic sensorineural hearing loss","volume":"26","author":"Banerjee","year":"2005","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.otorri.2009.03.008_bib26","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.otohns.2005.01.024","article-title":"Intratympanic dexamethasone for profound idiopathic sudden sensorineural hearing loss","volume":"132","author":"Battista","year":"2005","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.otorri.2009.03.008_bib27","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00405-004-0772-6","article-title":"Intratympanic dexamethasone with hyaluronic acid in the treatment of idiopathic sudden sensorineural hearing loss after failure of intravenous steroid and vasoactive therapy","volume":"262","author":"Gouveris","year":"2005","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.otorri.2009.03.008_bib28","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.otohns.2004.09.138","article-title":"Intratympanic steroid perfusion for refractory sudden sensorineural hearing loss","volume":"132","author":"Herr","year":"2005","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.otorri.2009.03.008_bib29","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00405-004-0876-z","article-title":"Transtympanic corticoid therapy for acute profound hearing loss","volume":"262","author":"Lautermann","year":"2005","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.otorri.2009.03.008_bib30","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.otohns.2005.05.015","article-title":"Intratympanic steroid injection for treatment of idiopathic sudden hearing loss","volume":"133","author":"Slattery","year":"2005","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.otorri.2009.03.008_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/01.mlg.0000245058.11866.15","article-title":"Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy","volume":"117","author":"Haynes","year":"2007","journal-title":"Laryngoscope"},{"key":"10.1016\/j.otorri.2009.03.008_bib32","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.otohns.2005.03.081","article-title":"Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study","volume":"134","author":"Xenellis","year":"2006","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.otorri.2009.03.008_bib33","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/000348940711600405","article-title":"Intratympanic steroids for idiopathic sudden sensorineural hearing loss","volume":"116","author":"Fitzgerald","year":"2007","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.otorri.2009.03.008_bib34","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1080\/00016480601126952","article-title":"Topical steroid therapy using the Silverstein Microwick in sudden sensorineural hearing loss after failure of conventional treatment","volume":"127","author":"Van Wijck","year":"2007","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.otorri.2009.03.008_bib35","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/MAO.0b013e31819225b5","article-title":"Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss","volume":"30","author":"Battaglia","year":"2009","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.otorri.2009.03.008_bib36","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3109\/00016489109131486","article-title":"Treatment of vestibular disorders","volume":"481","author":"Itoh","year":"1991","journal-title":"Acta Otolaryngol Suppl"},{"key":"10.1016\/j.otorri.2009.03.008_bib37","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0030-6665(20)30398-4","article-title":"Dexamethasone perfusion of the labyrinth plus intravenous dexamethasone for M\u00e9ni\u00e8re's disease","volume":"29","author":"Shea","year":"1996","journal-title":"Otolaryngol Clin North Am"},{"key":"10.1016\/j.otorri.2009.03.008_bib38","first-page":"196","article-title":"Dexamethasone inner ear perfusion for the treatment of Meniere's disease: a prospective, randomized, double-blind, crossover trial","volume":"19","author":"Silverstein","year":"1998","journal-title":"Am J Otol"},{"key":"10.1016\/j.otorri.2009.03.008_bib39","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1017\/S0022215100143610","article-title":"Transtympanic dexamethasone application in M\u00e9ni\u00e8re's disease: an alternative treatment for intractable vertigo","volume":"113","author":"Sennaroglu","year":"1999","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.otorri.2009.03.008_bib40","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000027730","article-title":"Intratympanic and systemic dexamethasone for M\u00e9ni\u00e8re's disease","volume":"62","author":"Hirvonen","year":"2000","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"10.1016\/j.otorri.2009.03.008_bib41","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1097\/00005537-200311000-00008","article-title":"Intratympanic steroids: do they acutely improve hearing in cases of cochlear hydrops?","volume":"113","author":"Hillman","year":"2003","journal-title":"Laryngoscope"},{"key":"10.1016\/j.otorri.2009.03.008_bib42","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/014556130408300611","article-title":"Intratympanic steroid perfusion for the treatment of M\u00e9ni\u00e8re's disease: a retrospective study","volume":"83","author":"Dodson","year":"2004","journal-title":"Ear Nose Throat J"},{"key":"10.1016\/j.otorri.2009.03.008_bib43","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/mao.0b013e31815dbafc","article-title":"Longitudinal results with intratympanic dexamethasone in the treatment of M\u00e9ni\u00e8re's disease","volume":"29","author":"Boleas-Aguirre","year":"2008","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.otorri.2009.03.008_bib44","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00005537-199701000-00012","article-title":"Intratympanic gentamicin for treatment of intractable Meniere's disease: a preliminary report","volume":"107","author":"Rauch","year":"1997","journal-title":"Laryngoscope"},{"key":"10.1016\/j.otorri.2009.03.008_bib45","first-page":"44","article-title":"Intratympanic gentamicin therapy for M\u00e9ni\u00e8re's disease","volume":"18","author":"Hirsch","year":"1997","journal-title":"Am J Otol"},{"key":"10.1016\/j.otorri.2009.03.008_bib46","first-page":"589","article-title":"Intratympanic gentamicin treatment for Meniere's disease","volume":"118","author":"McFeely","year":"1998","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.otorri.2009.03.008_bib47","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1080\/00016489850183359","article-title":"Intratympanic gentamicin in Meniere's disease","volume":"118","author":"Kaasinen","year":"1998","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.otorri.2009.03.008_bib48","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1097\/00005537-200008000-00014","article-title":"Intratympanic gentamicin for the treatment of unilateral Meniere's disease","volume":"110","author":"Kaplan","year":"2000","journal-title":"Laryngoscope"},{"key":"10.1016\/j.otorri.2009.03.008_bib49","first-page":"35","article-title":"Low-dose intratympanic gentamicin treatment for dizziness in M\u00e9ni\u00e8re's disease","volume":"29","author":"Longridge","year":"2000","journal-title":"J Otolaryngol"},{"key":"10.1016\/j.otorri.2009.03.008_bib50","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/000164801300102879","article-title":"Intratympanic therapy for M\u00e9ni\u00e8re's disease: effect of administration of low concentration of gentamicin","volume":"121","author":"Quaranta","year":"2001","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.otorri.2009.03.008_bib51","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/00129492-200207000-00018","article-title":"Efficacy of increased gentamicin concentration for intratympanic injection therapy in M\u00e9ni\u00e8re's disease","volume":"23","author":"Abou-Halawa","year":"2002","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.otorri.2009.03.008_bib52","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/00005537-200303000-00013","article-title":"Intratympanic gentamicin for intractable Meniere's disease","volume":"113","author":"Perez","year":"2003","journal-title":"Laryngoscope"},{"key":"10.1016\/j.otorri.2009.03.008_bib53","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/00005537-200305000-00009","article-title":"Long-term hearing outcome in patients receiving intratympanic gentamicin for M\u00e9ni\u00e8re's disease","volume":"113","author":"Wu","year":"2003","journal-title":"Laryngoscope"}],"container-title":["Acta Otorrinolaringol\u00f3gica Espa\u00f1ola"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001651909000685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001651909000685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T01:55:08Z","timestamp":1633917308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001651909000685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0001651909000685"],"URL":"https:\/\/doi.org\/10.1016\/j.otorri.2009.03.008","relation":{},"ISSN":["0001-6519"],"issn-type":[{"value":"0001-6519","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}